CLINICAL TRIAL / NCT05611918
REpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage Study
- Observational
- OPEN TO ACCRUAL
- NCT05611918
The Repeated Assessment of Survivors in ICH (REASSESS ICH)
The investigators propose to perform serial detailed cognitive, motor, behavioral, and blood collection follow-up using longitudinal structured telephone interviews of an anticipated 350 ICH survivors enrolled in Minimally Invasive Surgery Plus Alteplase for Intracerebral Hemorrhage Evacuation (MISTIE) III and ENRICH trials to identify specific cognitive and motor impairment and to perform RNA sequencing to evaluate for evidence of chronic inflammation. The investigators' expected sample size in 2022 accounts for mortality attrition of 10%/year.
